Insmed
INSM
99 hedge funds and large institutions have $834M invested in Insmed in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 17 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
88% more call options, than puts
Call options by funds: $5.69M | Put options by funds: $3.02M
50% more capital invested
Capital invested by funds: $557M → $834M (+$277M)
39% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 28
7% less funds holding
Funds holding: 106 → 99 (-7)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$13.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.6M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.64M |
| 4 |
Goldman Sachs
New York
|
+$4.02M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$13.8M |
| 2 |
JP Morgan Chase
New York
|
-$4.7M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.58M |
| 4 |
SAM
Senzar Asset Management
New York
|
-$2.45M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.23M |
INSM Hedge Fund Activity: Q3 2016 in Review
99 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2016, worth a combined $834M — up 50% from $557M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of INSM and 10 opened new positions — a net loss of 7 holders — while 28 trimmed existing stakes and 39 added.
The largest buyer was OrbiMed, adding an estimated $13.7M. The largest seller was Baker Bros. Advisors, cutting an estimated $13.8M.
- 99 institutional investors held Insmed (INSM) as of Q3 2016, down from 106 in Q2 2016.
- Funds reported $834M of Insmed stock for Q3 2016, up 50% quarter-over-quarter.
- 10 funds opened new Insmed positions in Q3 2016 and 17 closed out, a net change of -7 holders.
- The largest Insmed buyer in Q3 2016 was OrbiMed, an estimated $13.7M added.
- The largest Insmed seller in Q3 2016 was Baker Bros. Advisors, an estimated $13.8M sold.
Based on aggregated 13F filings for Q3 2016.